Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St set for higher open as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Abbott (ABT) gains as 'strong' performance tops Q3 expectations
October 18, 2023 8:04 AM EDTAbbott (NYSE: ABT) shares are up more than 2% premarket Wednesday after the company reported earnings, topping consensus expectations.
The medical device company reported Q3 EPS of $1.14, $0.04 better than the analyst estimate of $1.10, while revenue for the quarter came in at $10.1 billion versus the consensus... More
Abbott (ABT) Tops Q3 EPS by 4c, Raises Guidance
October 18, 2023 7:33 AM EDT(Updated - October 18, 2023 7:35 AM EDT)
Abbott (NYSE: ABT) reported Q3 EPS of $1.14, $0.04 better than the analyst estimate of $1.10 Revenue for the quarter came in at $10.1 billion versus the consensus estimate of $9.82 billion.
GUIDANCE:
Abbott sees FY2023 EPS of $4.42-$4.46, versus... More
